Insiders Updates Novabay Pharmaceuticals Inc’s latest rating changes from various analysts Novabay Pharmaceuticals Inc’s recently made public that its 10% Owner POPLAR POINT CAPITAL PARTNERS acquired Company’s shares for reported $12929.0
Insiders Updates NBY short interest surges, indicating growing pessimism among investors Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Novabay Pharmaceuticals
News 5 Trending Stocks to Trade This Morning The NASDAQ gained 1.0% and the S&P 500 advanced 0.3% in yesterday’s trading session, while the blue chip Dow Jones